Should Investors Be Worried About Moderna's Leadership Change?

Retrieved on: 2021-03-12 13:07:30

Tags for this article:

Click the tags to see associated articles and topics

Should Investors Be Worried About Moderna's Leadership Change?. View article details on hiswai:

Excerpt

Moderna (NASDAQ:MRNA) recently announced that Tal Zaks, the biotech's chief medical officer, is planning on leaving the company in late September.

Article found on: www.fool.com